메뉴 건너뛰기




Volumn 7, Issue 32, 2016, Pages 52436-52441

Intrapericardial bevacizumab safely and effectively treats malignant pericardial effusion in advanced cancer patients

Author keywords

Advanced cancer; Bevacizumab; Intrapericardial; Malignant pericardial effusion

Indexed keywords

BEVACIZUMAB; CISPLATIN; ERLOTINIB; GEMCITABINE; PEMETREXED; IMMUNOLOGICAL ANTINEOPLASTIC AGENT;

EID: 84982296436     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.9420     Document Type: Article
Times cited : (12)

References (34)
  • 1
    • 84860690425 scopus 로고    scopus 로고
    • Development of implants for sustained release of 5-fluorouracil using low molecular weight biodegradable polymers
    • Hanafy AF, El-Egaky AM, Mortada SA, Molokhia AM. Development of implants for sustained release of 5-fluorouracil using low molecular weight biodegradable polymers. Drug Discoveries and Therapeutics. 2009; 3: 287-295.
    • (2009) Drug Discoveries and Therapeutics , vol.3 , pp. 287-295
    • Hanafy, A.F.1    El-Egaky, A.M.2    Mortada, S.A.3    Molokhia, A.M.4
  • 3
    • 0022572450 scopus 로고
    • Secondary malignant lesions of the heart and pericardium in neoplastic disease
    • Skhvatsabaja LV. Secondary malignant lesions of the heart and pericardium in neoplastic disease. Oncology. 1986; 43: 103-106.
    • (1986) Oncology , vol.43 , pp. 103-106
    • Skhvatsabaja, L.V.1
  • 8
    • 84876204266 scopus 로고    scopus 로고
    • Intrapleural combination therapy with bevacizumab and cisplatin for non-small cell lung cancer-mediated malignant pleural effusion
    • Du N, Li X, Li F, Zhao H, Fan Z, Ma J, Fu Y, Kang H. Intrapleural combination therapy with bevacizumab and cisplatin for non-small cell lung cancer-mediated malignant pleural effusion. Oncology Reports. 2013; 29: 2332-2340.
    • (2013) Oncology Reports , vol.29 , pp. 2332-2340
    • Du, N.1    Li, X.2    Li, F.3    Zhao, H.4    Fan, Z.5    Ma, J.6    Fu, Y.7    Kang, H.8
  • 9
    • 33748475636 scopus 로고    scopus 로고
    • The use of bevacizumab to palliate symptomatic ascites in patients with refractory ovarian carcinoma
    • Numnum TM, Rocconi RP, Whitworth J, Barnes MN. The use of bevacizumab to palliate symptomatic ascites in patients with refractory ovarian carcinoma. Gynecologic Oncology. 2006; 102: 425-428.
    • (2006) Gynecologic Oncology , vol.102 , pp. 425-428
    • Numnum, T.M.1    Rocconi, R.P.2    Whitworth, J.3    Barnes, M.N.4
  • 10
    • 84979590540 scopus 로고    scopus 로고
    • Effective treatment for malignant pleural effusion and ascites with combined therapy of bevacizumab and cisplatin
    • Jiang L, Li P, Gong Z, Hu B, Ma J, Wang J, Chu H, Zhang L, Sun P, Chen J. Effective treatment for malignant pleural effusion and ascites with combined therapy of bevacizumab and cisplatin. Anticancer Research. 2016; 36: 1313-1318.
    • (2016) Anticancer Research , vol.36 , pp. 1313-1318
    • Jiang, L.1    Li, P.2    Gong, Z.3    Hu, B.4    Ma, J.5    Wang, J.6    Chu, H.7    Zhang, L.8    Sun, P.9    Chen, J.10
  • 11
    • 0017692936 scopus 로고
    • Carcinomatous involvement of the pleura: an analysis of 96 patients
    • Chernow B, Sahn SA. Carcinomatous involvement of the pleura: an analysis of 96 patients. The American Journal of Medicine. 1977; 63:695-702.
    • (1977) The American Journal of Medicine , vol.63 , pp. 695-702
    • Chernow, B.1    Sahn, S.A.2
  • 12
    • 0016195162 scopus 로고
    • Lymphatic drainage of the peritoneal cavity and its significance in ovarian cancer
    • Feldman GB, Knapp RC. Lymphatic drainage of the peritoneal cavity and its significance in ovarian cancer. American Journal of Obstetrics and Gynecology. 1974; 119: 991-994.
    • (1974) American Journal of Obstetrics and Gynecology , vol.119 , pp. 991-994
    • Feldman, G.B.1    Knapp, R.C.2
  • 13
    • 0013943030 scopus 로고
    • Metastatic carcinoma of the pleura
    • Meyer PC. Metastatic carcinoma of the pleura. Thorax. 1966; 21: 437-443.
    • (1966) Thorax , vol.21 , pp. 437-443
    • Meyer, P.C.1
  • 14
    • 0015385809 scopus 로고
    • The role of lymphatic obstruction in the formation of ascites in a murine ovarian carcinoma
    • Feldman GB, Knapp RC, Order SE, Hellman S. The role of lymphatic obstruction in the formation of ascites in a murine ovarian carcinoma. Cancer Research. 1972; 32: 1663-1666.
    • (1972) Cancer Research , vol.32 , pp. 1663-1666
    • Feldman, G.B.1    Knapp, R.C.2    Order, S.E.3    Hellman, S.4
  • 15
    • 0021351361 scopus 로고
    • Prevention of carcinomatosis and bloody malignant ascites in the rat by an inhibitor of angiogenesis
    • Heuser LS, Taylor SH, Folkman J. Prevention of carcinomatosis and bloody malignant ascites in the rat by an inhibitor of angiogenesis. The Journal of Surgical Research. 1984; 36: 244-250.
    • (1984) The Journal of Surgical Research , vol.36 , pp. 244-250
    • Heuser, L.S.1    Taylor, S.H.2    Folkman, J.3
  • 17
    • 0017258035 scopus 로고
    • Tumor angiogenesis activity in cells grown in tissue culture
    • Klagsbrun M, Knighton D, Folkman J. Tumor angiogenesis activity in cells grown in tissue culture. Cancer Research. 1976; 36: 110-114.
    • (1976) Cancer Research , vol.36 , pp. 110-114
    • Klagsbrun, M.1    Knighton, D.2    Folkman, J.3
  • 18
    • 62349103659 scopus 로고    scopus 로고
    • Diagnostic value of vascular endothelial growth factor and endostatin in malignant pleural effusions
    • Zhou WB, Bai M, Jin Y. Diagnostic value of vascular endothelial growth factor and endostatin in malignant pleural effusions. International Journal of Tuberculosis and Lung Disease. 2009; 13: 381-386.
    • (2009) International Journal of Tuberculosis and Lung Disease , vol.13 , pp. 381-386
    • Zhou, W.B.1    Bai, M.2    Jin, Y.3
  • 21
    • 84962224315 scopus 로고    scopus 로고
    • Greater efficacy of chemotherapy plus bevacizumab compared to chemoand targeted therapy alone on non-small cell lung cancer patients with brain metastasis
    • Tang N, Guo J, Zhang Q, Wang Y, Wang Z. Greater efficacy of chemotherapy plus bevacizumab compared to chemoand targeted therapy alone on non-small cell lung cancer patients with brain metastasis. Oncotarget. 2016; 7: 3635-3644 doi: 10.18632/oncotarget.6184.
    • (2016) Oncotarget , vol.7 , pp. 3635-3644
    • Tang, N.1    Guo, J.2    Zhang, Q.3    Wang, Y.4    Wang, Z.5
  • 22
    • 70350435581 scopus 로고    scopus 로고
    • Monoclonal anti-vascular endothelial growth factor antibody reduces fluid volume in an experimental model of inflammatory pleural effusion
    • Ribeiro SC, Vargas FS, Antonangelo L, Marchi E, Genofre EH, Acencio MM, Teixeira LR. Monoclonal anti-vascular endothelial growth factor antibody reduces fluid volume in an experimental model of inflammatory pleural effusion. Respirology. 2009; 14: 1188-1193.
    • (2009) Respirology , vol.14 , pp. 1188-1193
    • Ribeiro, S.C.1    Vargas, F.S.2    Antonangelo, L.3    Marchi, E.4    Genofre, E.H.5    Acencio, M.M.6    Teixeira, L.R.7
  • 23
    • 0005419856 scopus 로고    scopus 로고
    • Significant expression of vascular endothelial growth factor/vascular permeability factor in mouse ascites tumors
    • Luo JC, Yamaguchi S, Shinkai A, Shitara K, Shibuya M. Significant expression of vascular endothelial growth factor/vascular permeability factor in mouse ascites tumors. Cancer Research. 1998; 58: 2652-2660.
    • (1998) Cancer Research , vol.58 , pp. 2652-2660
    • Luo, J.C.1    Yamaguchi, S.2    Shinkai, A.3    Shitara, K.4    Shibuya, M.5
  • 24
    • 0345060442 scopus 로고    scopus 로고
    • Vascular endothelial growth factor-trap decreases tumor burden, inhibits ascites, and causes dramatic vascular remodeling in an ovarian cancer model
    • Byrne AT, Ross L, Holash J, Nakanishi M, Hu L, Hofmann JI, Yancopoulos GD, Jaffe RB. Vascular endothelial growth factor-trap decreases tumor burden, inhibits ascites, and causes dramatic vascular remodeling in an ovarian cancer model. Clinical Cancer Research. 2003; 9: 5721-5728.
    • (2003) Clinical Cancer Research , vol.9 , pp. 5721-5728
    • Byrne, A.T.1    Ross, L.2    Holash, J.3    Nakanishi, M.4    Hu, L.5    Hofmann, J.I.6    Yancopoulos, G.D.7    Jaffe, R.B.8
  • 25
    • 0034145605 scopus 로고    scopus 로고
    • Inhibition of malignant ascites and growth of human ovarian carcinoma by oral administration of a potent inhibitor of the vascular endothelial growth factor receptor tyrosine kinases
    • Xu L, Yoneda J, Herrera C, Wood J, Killion JJ, Fidler IJ. Inhibition of malignant ascites and growth of human ovarian carcinoma by oral administration of a potent inhibitor of the vascular endothelial growth factor receptor tyrosine kinases. International Journal of Oncology. 2000; 16: 445-454.
    • (2000) International Journal of Oncology , vol.16 , pp. 445-454
    • Xu, L.1    Yoneda, J.2    Herrera, C.3    Wood, J.4    Killion, J.J.5    Fidler, I.J.6
  • 27
    • 0030856731 scopus 로고    scopus 로고
    • Humanization of an anti-vascular endothelial growth factor monoclonal antibody for the therapy of solid tumors and other disorders
    • Presta LG, Chen H, O'Connor SJ, Chisholm V, Meng YG, Krummen L, Winkler M, Ferrara N. Humanization of an anti-vascular endothelial growth factor monoclonal antibody for the therapy of solid tumors and other disorders. Cancer Research. 1997; 57: 4593-4599.
    • (1997) Cancer Research , vol.57 , pp. 4593-4599
    • Presta, L.G.1    Chen, H.2    O'Connor, S.J.3    Chisholm, V.4    Meng, Y.G.5    Krummen, L.6    Winkler, M.7    Ferrara, N.8
  • 28
    • 1842415455 scopus 로고    scopus 로고
    • Vessel counts and expression of vascular endothelial growth factor as prognostic factors in node-negative colon cancer
    • Takahashi Y, Tucker SL, Kitadai Y, Koura AN, Bucana CD, Cleary KR, Ellis LM. Vessel counts and expression of vascular endothelial growth factor as prognostic factors in node-negative colon cancer. Archives of Surgery. 1997; 132: 541-546.
    • (1997) Archives of Surgery , vol.132 , pp. 541-546
    • Takahashi, Y.1    Tucker, S.L.2    Kitadai, Y.3    Koura, A.N.4    Bucana, C.D.5    Cleary, K.R.6    Ellis, L.M.7
  • 29
    • 84943369737 scopus 로고    scopus 로고
    • Sustained response of malignant pericardial effusion to intrapericardial bevacizumab in an advanced lung cancer patient: a case report and literature review
    • Chen D, Zhang Y, Shi F, Li M, Zhu H, Kong L, Yu J. Sustained response of malignant pericardial effusion to intrapericardial bevacizumab in an advanced lung cancer patient: a case report and literature review. OncoTargets and Therapy. 2015; 8: 2767-2770.
    • (2015) OncoTargets and Therapy , vol.8 , pp. 2767-2770
    • Chen, D.1    Zhang, Y.2    Shi, F.3    Li, M.4    Zhu, H.5    Kong, L.6    Yu, J.7
  • 32
    • 84937117699 scopus 로고    scopus 로고
    • BEYOND: a randomized, double-blind, placebo-controlled, multicenter, phase III study of first-line carboplatin/paclitaxel plus bevacizumab or placebo in Chinese patients with advanced or recurrent nonsquamous non-small-cell lung cancer
    • Zhou C, Wu YL, Chen G, Liu X, Zhu Y, Lu S, Feng J, He J, Han B, Wang J, Jiang G, Hu C, et al. BEYOND: a randomized, double-blind, placebo-controlled, multicenter, phase III study of first-line carboplatin/paclitaxel plus bevacizumab or placebo in Chinese patients with advanced or recurrent nonsquamous non-small-cell lung cancer. Journal of Clinical Oncology. 2015; 33: 2197-2204.
    • (2015) Journal of Clinical Oncology , vol.33 , pp. 2197-2204
    • Zhou, C.1    Wu, Y.L.2    Chen, G.3    Liu, X.4    Zhu, Y.5    Lu, S.6    Feng, J.7    He, J.8    Han, B.9    Wang, J.10    Jiang, G.11    Hu, C.12
  • 34
    • 84926327497 scopus 로고    scopus 로고
    • The efficacy of pemetrexed and bevacizumab intrapleural injection for malignant pleural mesothelioma-mediated malignant pleural effusion
    • Chen D, Li X, Zhao H, Fu Y, Yao F, Hu J, Du N. The efficacy of pemetrexed and bevacizumab intrapleural injection for malignant pleural mesothelioma-mediated malignant pleural effusion. Indian Journal of Cancer. 2014; 51: e82-85.
    • (2014) Indian Journal of Cancer , vol.51 , pp. e82-e85
    • Chen, D.1    Li, X.2    Zhao, H.3    Fu, Y.4    Yao, F.5    Hu, J.6    Du, N.7


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.